Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers:
4.1.1.1. Rising prevalence of ear, nose and throat disorders
4.1.1.2. Increasing technological advancements
4.1.2. Restraints:
4.1.2.1. High cost associated with these devices
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Regulatory Analysis
5.3. Supply Chain Analysis
5.4. Pricing Analysis
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
6.1.2. Market Attractiveness Index, By Product Type Segment
6.2. Diagnostic Devices
6.2.1. Introduction
6.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
6.2.3. Endoscopes
6.2.3.1. Rigid Endoscopes
6.2.3.1.1. Otoscopes
6.2.3.1.2. Sinuscopes
6.2.3.2. Flexible Endoscopes
6.2.3.2.1. Laryngoscopes
6.2.3.2.2. Pharyngoscopes
6.2.3.2.3. Other Flexible Endoscopes
6.2.4. Robot-Assisted Endoscope
6.2.5. Hearing Screening Device
6.2.6. Other Diagnostic Devices
6.3. Surgical Devices
6.3.1. Radiofrequency Handpieces
6.3.2. Powered Surgical Instrument
6.3.3. Otological Drill Burrs
6.3.4. ENT Hand Instruments
6.3.5. Balloon Sinus Dilation Devices
6.3.6. Sinus Dilation Devices
6.3.7. Nasal Packing Devices
6.3.8. Other Surgical Devices
6.4. Hearing Aids
6.4.1. In-the-ear (ITE)
6.4.2. Receiver ITE
6.4.3. Behind-the-ear
6.4.4. Canal hearing aids ITC, CIC, IIC
6.4.5. Other Hearing Aids
6.5. Image-guided Surgery Systems
6.6. Others
7. By End User
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
7.1.2. Market Attractiveness Index, By End User Segment
7.2. Hospitals
7.2.1.1. Introduction
7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. ENT Clinics
7.4. Others
8. By Region
8.1. Introduction
8.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
8.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
8.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.2.5.1. U.S.
8.2.5.2. Canada
8.2.5.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
8.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
8.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.3.5.1. Germany
8.3.5.2. U.K.
8.3.5.3. France
8.3.5.4. Italy
8.3.5.5. Spain
8.3.5.6. Rest of Europe
8.4. South America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.4.5.1. Brazil
8.4.5.2. Argentina
8.4.5.3. Rest of South America
8.5. Asia Pacific
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.5.5.1. China
8.5.5.2. India
8.5.5.3. Japan
8.5.5.4. Australia
8.5.5.5. Rest of Asia Pacific
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9. Competitive Landscape
9.1. Key Developments and Strategies
9.2. Company Share Analysis
9.3. Disease Types Benchmarking
9.4. List of Key Companies to Watch
10. Company Profiles
10.1. Atos Medical AB
10.1.1. Company Overview
10.1.2. Disease Type Portfolio and Description
10.1.3. Key Highlights
10.1.4. Financial Overview
10.2. Cochlear Ltd.
10.3. Freudenberg SE
10.4. HILL-ROM HOLDINGS, INC.
10.5. Acclarent, Inc. (Johnson & Johnson)
10.6. Medtronic Plc.
10.7. Olympus Corporation
10.8. Sonova Group
10.9. Starkey Hearing Technologies
10.10. Stryker Corporation
LIST NOT EXHAUSTIVE
11. Global Otorhinolaryngology Devices Market – DataM
11.1. Appendix
11.2. About Us and End User
11.3. Contact Us